MAVIRET
MAVIRET
Approved
DIN Number
02467550
Drug Class
Human
Market Date
Sep 13, 2017
Company
HC
Abbvie Corporation
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02467550
AIG Number0259390001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J05AP57 GLECAPREVIR AND PIBRENTASVIR
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification08:18.40.24
Health Canada Classification
ACTIVE INGREDIENTS (2)
GLECAPREVIRActive
Strength: 100 MG
Monograph: GLECAPREVIR
PIBRENTASVIRActive
Strength: 40 MG
Monograph: PIBRENTASVIR